- Home
- HPP vs EBS Comparison
HPP vs EBS Comparison
Compare HPP & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HPP | EBS |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.0M | 595.6M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | HPP | EBS |
|---|---|---|
| Price | $6.31 | $10.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $16.35 | $15.00 |
| AVG Volume (30 Days) | ★ 1.5M | 522.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.76 |
| EPS | N/A | ★ 1.89 |
| Revenue | N/A | ★ $1,043,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.32 | $15.21 |
| P/E Ratio | ★ N/A | $5.74 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.67 | $4.02 |
| 52 Week High | $14.95 | $14.06 |
Technical Indicators
Market Signals| Indicator | HPP | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 27.55 | 45.93 |
| Support Level | $5.55 | $10.50 |
| Resistance Level | $11.26 | $12.60 |
| Average True Range (ATR) | 0.55 | 0.53 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 13.22 | 46.21 |
Price Performance
Historical ComparisonAbout HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.